Literature DB >> 28886009

Tau-mediated iron export prevents ferroptotic damage after ischemic stroke.

Q-Z Tuo1,2,3, P Lei2,3, K A Jackman2, X-L Li2,4, H Xiong3, X-L Li2,4, Z-Y Liuyang1, L Roisman5, S-T Zhang3, S Ayton2, Q Wang3, P J Crouch5, K Ganio2, X-C Wang1, L Pei6, P A Adlard2, Y-M Lu1, R Cappai5, J-Z Wang1, R Liu1, A I Bush2.   

Abstract

Functional failure of tau contributes to age-dependent, iron-mediated neurotoxicity, and as iron accumulates in ischemic stroke tissue, we hypothesized that tau failure may exaggerate ischemia-reperfusion-related toxicity. Indeed, unilateral, transient middle cerebral artery occlusion (MCAO) suppressed hemispheric tau and increased iron levels in young (3-month-old) mice and rats. Wild-type mice were protected by iron-targeted interventions: ceruloplasmin and amyloid precursor protein ectodomain, as well as ferroptosis inhibitors. At this age, tau-knockout mice did not express elevated brain iron and were protected against hemispheric reperfusion injury following MCAO, indicating that tau suppression may prevent ferroptosis. However, the accelerated age-dependent brain iron accumulation that occurs in tau-knockout mice at 12 months of age negated the protective benefit of tau suppression against MCAO-induced focal cerebral ischemia-reperfusion injury. The protective benefit of tau knockout was revived in older mice by iron-targeting interventions. These findings introduce tau-iron interaction as a pleiotropic modulator of ferroptosis and ischemic stroke outcome.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28886009     DOI: 10.1038/mp.2017.171

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  152 in total

Review 1.  Ferroptosis and kidney diseases.

Authors:  Shumei Tang; Xiangcheng Xiao
Journal:  Int Urol Nephrol       Date:  2019-11-25       Impact factor: 2.370

Review 2.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

3.  Inhibition of ferroptosis attenuates tissue damage and improves long-term outcomes after traumatic brain injury in mice.

Authors:  Bao-Shu Xie; Yi-Qin Wang; Yong Lin; Qing Mao; Jun-Feng Feng; Guo-Yi Gao; Ji-Yao Jiang
Journal:  CNS Neurosci Ther       Date:  2018-09-28       Impact factor: 5.243

4.  Stroke: Tau - a new target in acute brain ischaemia.

Authors:  Peter Sidaway
Journal:  Nat Rev Neurol       Date:  2017-09-29       Impact factor: 42.937

Review 5.  Tau Proteins and Tauopathies in Alzheimer's Disease.

Authors:  Fong Ping Chong; Khuen Yen Ng; Rhun Yian Koh; Soi Moi Chye
Journal:  Cell Mol Neurobiol       Date:  2018-01-03       Impact factor: 5.046

6.  Empowerment of 15-Lipoxygenase Catalytic Competence in Selective Oxidation of Membrane ETE-PE to Ferroptotic Death Signals, HpETE-PE.

Authors:  Tamil S Anthonymuthu; Elizabeth M Kenny; Indira Shrivastava; Yulia Y Tyurina; Zachary E Hier; Hsiu-Chi Ting; Haider H Dar; Vladimir A Tyurin; Anastasia Nesterova; Andrew A Amoscato; Karolina Mikulska-Ruminska; Joel C Rosenbaum; Gaowei Mao; Jinming Zhao; Marcus Conrad; John A Kellum; Sally E Wenzel; Andrew P VanDemark; Ivet Bahar; Valerian E Kagan; Hülya Bayır
Journal:  J Am Chem Soc       Date:  2018-12-17       Impact factor: 15.419

Review 7.  The Chemistry and Biology of Ferroptosis.

Authors:  Brent R Stockwell; Xuejun Jiang
Journal:  Cell Chem Biol       Date:  2020-04-16       Impact factor: 8.116

Review 8.  Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders.

Authors:  Jia-Rui Wu; Qing-Zhang Tuo; Peng Lei
Journal:  J Mol Neurosci       Date:  2018-08-25       Impact factor: 3.444

9.  MiR-199a-5p inhibition protects cognitive function of ischemic stroke rats by AKT signaling pathway.

Authors:  Xianghui Zhang; Guan'en Zhou
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

10.  Small Molecule Regulators of Ferroptosis.

Authors:  Sylvain Debieu; Stéphanie Solier; Ludovic Colombeau; Antoine Versini; Fabien Sindikubwabo; Alison Forrester; Sebastian Müller; Tatiana Cañeque; Raphaël Rodriguez
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.